Company profile: IsoPlexis

1.1 - Company Overview

IsoPlexis

Headquarter: United States

Founded: 20XX🔒

Employees: 100-500🔒

🌐 Website

Company description

Provider of single-cell detection technology that identifies a wide range of patient immune responses at the single-cell level. Its platform assesses the safety and efficacy of therapeutics and monitors disease progression to support improved therapeutic development and inform physician decisions.

Products and services

🔒

Key contacts

🔒

Financial details

🔒

1.2 - Competitors and similar companies to IsoPlexis

Origo Biopharma

HQ: Spain Website

Description: Provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Origo Biopharma company profile →

Proxima Therapeutics

HQ: United States Website

Description: Provider of radiation delivery systems for treating solid cancerous tumors, with an initial focus on brain and breast cancer, including the GliaSite RTS for brain cancer and the MammoSite RTS for breast cancer.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Proxima Therapeutics company profile →

SonoCiné

HQ: United States Website

Description: Provider of an imaging solution for breast cancer screening, which the company develops and markets.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full SonoCiné company profile →

Delphinus Medical

HQ: United States Website

Description: Provider of breast cancer screening solutions for hospitals and imaging clinics, developing, commercializing, and servicing the SoftVue 3D Whole Breast Ultrasound Tomography, a 3D whole breast ultrasound system for dense breast screening that increases cancer detection by 20% when used alongside mammography.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Delphinus Medical company profile →

Totus Medicines

HQ: United States Website

Description: Provider of AI/ML-driven small-molecule drug discovery using innovative DNA-encoded covalent libraries. Offers the Totus Platform combining AI/ML, cellular analysis, and covalent chemistry for high-throughput genome-wide screening, plus an oncology pipeline including TOS-358, a PI3Kα inhibitor for breast, colorectal, and lung cancers.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Totus Medicines company profile →

🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒

🔒 View all strategic buyers with complete profiles

Start Free Trial →

2.2 - Strategic buyer groups for IsoPlexis

🔒

Buyer group 1: ████████ ████████

●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 2: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 3: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔓 Unlock all detailed buyer group breakdowns with complete company profiles

Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to IsoPlexis

Buyout Funds
50+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US buyout funds investing in IsoPlexis's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe buyout funds in IsoPlexis's sector and industry vertical
View Funds →

2.2 - Growth funds investing in similar companies to IsoPlexis

Growth Equity Funds
40+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US growth equity funds investing in IsoPlexis's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe growth equity funds investing in IsoPlexis's sector and industry vertical
View Funds →

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for IsoPlexis

4.2 - Public trading comparable groups for IsoPlexis

🔒

Comparable group 1: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 2: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 3: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to IsoPlexis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA

🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About IsoPlexis

What does IsoPlexis do?

IsoPlexis is a provider of single-cell detection technology that identifies a wide range of patient immune responses at the single-cell level. Its platform assesses the safety and efficacy of therapeutics and monitors disease progression to support improved therapeutic development and inform physician decisions.

Who are IsoPlexis's competitors?

IsoPlexis's competitors and similar companies include Origo Biopharma, Proxima Therapeutics, SonoCiné, Delphinus Medical, and Totus Medicines.

Where is IsoPlexis headquartered?

IsoPlexis is headquartered in United States.

How many employees does IsoPlexis have?

IsoPlexis has 1,000 employees 🔒.

When was IsoPlexis founded?

IsoPlexis was founded in 2010 🔒.

What sector and industry vertical is IsoPlexis in?

IsoPlexis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for IsoPlexis

Who are the top strategic acquirers in IsoPlexis's sector and industry

Top strategic M&A buyers and acquirers in IsoPlexis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for IsoPlexis?

Top strategic M&A buyers groups and sectors for IsoPlexis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in IsoPlexis's sector and industry vertical

Which are the top PE firms investing in IsoPlexis's sector and industry vertical?

Top PE firms investing in IsoPlexis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in IsoPlexis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in IsoPlexis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in IsoPlexis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to IsoPlexis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in IsoPlexis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for IsoPlexis?

The key public trading comparables and valuation benchmarks for IsoPlexis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for IsoPlexis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for IsoPlexis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in IsoPlexis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for IsoPlexis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in IsoPlexis's' sector and industry vertical?

Access recent funding rounds and capital raises in IsoPlexis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for IsoPlexis

Start Free Trial Book a Demo